Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
439 |
|
| Actual shortage: | 60 (14%) | |
| Anticipated shortage: | 13 (3%) | |
| Avoided shortage: | 8 (2%) | |
| Resolved: | 358 (82%) | |
Discontinuation Reports |
68 |
|
| To be discontinued: | 8 (12%) | |
| Discontinued: | 51 (75%) | |
| Reversed: | 9 (13%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (15%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-02-13 | 2024-04-04 | 219378 |
| GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-26 | 2024-03-27 | 223453 |
| GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-26 | 2024-03-26 | 223456 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2018-10-01 | 2018-10-31 | 62786 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2018-10-01 | 2018-10-31 | 62789 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2019-04-26 | 2019-06-04 | 82512 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2019-06-10 | 2019-11-28 | 86038 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2020-03-10 | 2021-02-10 | 108341 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2020-03-10 | 2021-09-14 | 108344 |
| IRBESARTAN | 75MG | TABLET | Resolved | 2020-03-10 | 2021-07-08 | 108347 |
| IRBESARTAN | 150MG | TABLET | Resolved | 2023-06-27 | 2023-11-13 | 196716 |
| IRBESARTAN | 300MG | TABLET | Resolved | 2023-10-23 | 2024-02-29 | 207903 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2018-03-07 | 2018-04-13 | 42112 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2018-08-14 | 2018-09-05 | 58073 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2019-01-28 | 2019-04-09 | 73693 |
| IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Resolved | 2020-01-20 | 2020-03-04 | 103707 |
| IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Resolved | 2020-01-20 | 2021-09-14 | 103710 |
| IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Resolved | 2020-03-10 | 2020-10-21 | 108338 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2020-03-10 | 2021-09-14 | 108350 |
| IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2024-01-30 | 2024-03-17 | 217829 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACEBUTOLOL | Discontinued | 2019-01-22 | 2019-01-22 | 73224 | ||
| ACEBUTOLOL | Discontinued | 2019-01-22 | 2019-01-22 | 73228 | ||
| ACEBUTOLOL | Discontinued | 2019-01-22 | 2019-01-22 | 73233 | ||
| ACYCLOVIR | 400MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4942 |
| ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144035 |
| ALPRAZOLAM | 0.50MG | TABLET | Discontinued | 2021-08-12 | 2021-12-17 | 144038 |
| ALPRAZOLAM | 0.50MG | TABLET | Discontinued | 2021-08-12 | 2021-08-12 | 144041 |
| AMOXICILLIN | 125MG | GRANULES FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4933 |
| AMOXICILLIN | 125MG | GRANULES FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4939 |
| AZATHIOPRINE | 50MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4899 |
| BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
| BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |
| CILAZAPRIL | 2.5MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4918 |
| CILAZAPRIL | 1MG | TABLET | Discontinued | 2017-08-02 | 2017-08-02 | 17969 |
| CIPROFLOXACIN | 750MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4924 |
| CLINDAMYCIN | 150MG | CAPSULE | Reversed | 2017-03-31 | 2017-07-31 | 4950 |
| CLINDAMYCIN | 300MG | CAPSULE | Reversed | 2017-03-31 | 2017-07-31 | 4956 |
| CLINDAMYCIN | Discontinued | 2020-02-27 | 2020-02-27 | 107379 | ||
| CLINDAMYCIN | Discontinued | 2020-02-27 | 2020-02-27 | 107383 | ||
| DILTIAZEM CD | 120MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2412 |